Beschreibung

Senior Director Global Product Strategy - Lung Cancer Therapies
Mainz, Germany; Cambridge, US; London, United Kingdom | full time | Job ID:9344

We are seeking a strategic, science-driven leader to join our Global Product Strategy team as Senior Director Lung Cancer Portfolio. This position plays a pivotal role in shaping the future of one of our most commercially and scientifically important oncology indications.

The role will focus heavily on new product planning and early commercial strategy, partnering closely with R&D, clinical, medical, and regulatory teams to inform development decisions and prepare the path to launch. As part of a growing commercial organization with presence in the US and Germany, this position requires hands-on leadership, deep oncology market insight, and a strong understanding of how to position early assets for future success in a competitive global environment.

This is a critical value driver for the company, and the role offers the opportunity to influence the strategic direction of a high-priority solid tumor program with global potential.
Lead global commercial strategy development for the lung cancer portfolio, with a focus on indication prioritization, early positioning, and value-focused lifecycle strategy
Drive new product planning activities from preclinical/early clinical through registrational development, supporting strategic TPP shaping, unmet need assessment, competitive differentiation, and commercial viability
Partner cross-functionally with R&D, clinical development, translational research, regulatory, and medical affairs to embed commercial perspectives into key decisions
Lead or co-lead commercial input into early launch readiness planning, with emphasis on evidence strategy, access considerations, and strategic stakeholder engagement
Provide deep insights into the US oncology market while ensuring alignment with global perspectives
Contribute to cross-functional governance processes, development strategy forums, and scenario planning efforts
Support external interactions where needed (e.g., advisory boards, co-development partners, select KOL discussions) in alignment with medical and development leadership
Work collaboratively across the internal team to ensure that the lung cancer portfolio is progressing in line with both scientific excellence and commercial ambition

8-12+ years of relevant experience in oncology commercial strategy, new product planning, launch readiness, or asset strategy roles
Strong track record in solid tumors, ideally with direct or adjacent lung, head and neck cancer experience
Significant experience in early-stage commercialization, including product concept shaping, indication assessment, and early launch strategy
Ability to partner effectively with R&D, including familiarity with oncology clinical trial design, regulatory pathways, and biomarker-driven development
Demonstrated understanding of the US oncology landscape and stakeholder needs; experience&understanding with EU and otthe major markets
Strong scientific acumen combined with a highly strategic mindset and the ability to navigate ambiguity in a pre-commercial environment
Experience working in global or cross-regional roles, ideally within biotech or fast-paced oncology-focused companies
Advanced degree (PhD, PharmD, MD, or MBA) strongly preferred
BioNTech is committed to the wellbeing of our team members and offers a variety of benefits in support of our diverse employee base. We offer competitive remuneration packages which is determined by the specific role, location of employment and also the selected candidate’s qualifications and experience.

Note: The availability, eligibility and design of the listed benefits may vary depending on the location. The final requirements for the individual use of our benefits are based on the company's internal policies and applicable law.